Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies Buys Certain Assets of Indian Firm Labindia

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies today announced a definitive agreement to buy certain assets from Indian firm Labindia for an undisclosed amount.

Labindia has been a distributor of Life Tech's Applied Biosystems products, including the SOLiD sequencing system and Ambion RNA reagents, since 1994. The deal creates a full service business, allowing Life Tech to supply ABI and Invitrogen products directly to customers, the company said in a statement.

Financial terms were not disclosed.

Based in New Delhi, Labindia markets and manufactures instruments for and provides services to the pharmaceutical, biotech, and life sciences industries. About 100 employees of Labindia will join Life Tech, resulting in a 200 person organization with operations throughout India.

India has been one of the fastest growing regions in the biotech market in recent years, experiencing double-digit growth. In Life Tech's statement, Mark Smedley, head of the Asia Pacific region for the company, said the main reason for the purchase was to fulfill demand from customers in the region, "and by developing a more direct connection with them, better serve their needs with superior products, service, and customer support."

The acquisition is expected to close before the end of the year and is not expected to have a material impact on Life Tech's financials in fiscal 2010, the company said.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.